Immune Interactions in Hepatic Fibrosis
Section snippets
Stromal microenvironments in chronic inflammatory disease
A characteristic feature of chronic liver disease is the presence of a persistent inflammatory infiltrate associated with regions of fibrosis and matrix remodeling. Although macrophages play an important role in the initiation and resolution of fibrosis, fibroblasts are the most numerous cells within the liver stroma and are primarily responsible for the synthesis of the extracellular matrix (ECM).6 Fibroblasts provide an architectural framework for tissues, and regulate important homeostatic
Macrophages regulate the induction and resolution of liver fibrosis
Many of the cells that play an important role in the immediate innate immune response, including neutrophils and mast cells, make little contribution to tissue fibrosis, and natural killer (NK) cells actually suppress fibrosis by killing activated myofibroblasts, possibly by tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)–dependent mechanisms,23, 24, 25 which may explain why many acute inflammatory reactions in the liver resolve without scarring.26, 27 On the other hand,
Stromal cells modulate the differentiation and function of antigen-presenting cells
The noninflamed liver contains a subset of myeloid DC that preferentially secrete IL-10 and induce IL-10 secretion in responding T cells.43, 44 These DC may play an important role in suppressing damaging immune responses in noninflammatory states. In the normal human liver, most DC are CD16+ and express high levels of CX3CL1. CD16+ circulating monocytes can differentiate into DC during the process of transendothelial migration45 and this process may be enhanced by interactions with fibroblasts.
Hepatic stellate cell activation in the liver promotes chronic inflammation
Liver myofibroblasts contribute to leukocyte recruitment to the injured liver by secreting cytokines, chemokines, and other chemoattractants, such as platelet-activating factor and complement proteins.54, 55, 56 In most circumstances, inflammation resolves once the initiating stimulus has been removed, but in some conditions, inflammation persists, resulting in chronic hepatitis and fibrogenesis.57 The switch from acute resolving to chronic persistent hepatitis is associated with the
Hepatic stellate cell activation is associated with leukocyte recruitment
Quiescent HSC are specialized pericytes found immediately adjacent to the sinusoids in the space of Disse. They maintain endothelial integrity by secreting angiogenic peptides in response to bidirectional interactions with the overlying endothelium.73 The expression of markers associated with stem cells such as CD133, Thy-1 (CD90), nanog, and Oct-4, and their ability to transdifferentiate into hepatocytes and endothelial-like cells suggest that HSC should also be regarded as progenitor cells.73
Migration and positioning of T cells are determined by patterns of cytokine and chemokine secretion within the stroma
The liver responds to injury by recruiting leukocytes from the circulation, expanding populations of scar-forming fibroblasts, and positioning the inflammatory infiltrate within the modified neomatrix. An effective hepatic immune response requires that leukocytes be recruited to the liver and then appropriately positioned at sites of injury.57 Leukocyte adhesion to endothelial cells is a prerequisite for recruitment into tissue and is regulated by a sequence of interactions in which the
Activated hepatic stellate cells modulate recruitment and positioning of leukocytes within the liver
As a consequence of being situated between the endothelium and parenchyma, HSC can participate in the recruitment of leukocytes into the liver. The first evidence that activated liver myofibroblasts contributed to liver inflammation came from the observation that CCL2 in HSC-conditioned media promoted vigorous monocyte chemotaxis.54 CCL2 also recruits memory T cells, basophils, and DC, suggesting it may be an important recruitment signal involved in chronic inflammation.102, 103 Studies in rat
Direct interactions with activated liver fibroblasts retain lymphocytes in tissue and prevent resolution of inflammation
The close temporal and spatial association between infiltrating lymphocytes and fibrosis has been recognized for many years, but the cellular interactions are poorly understood. In other tissues, T cells and B cells rely on cellular elements within the stroma for structural anchorage and directed migration. Thus, within secondary lymph nodes, fibroblastic reticular cells provide the adhesive scaffold that facilitates lymphocyte migration within the lymph node and that maintains the zonal
Stromal interactions with infiltrating lymphocytes shape fibrogenesis in chronic hepatitis
Although interactions among macrophages and fibroblasts are critical for fibrosis induction and resolution,129 the role of the adaptive immune system is less well defined (Fig. 4). Nevertheless, good evidence suggests that T cells and B cells are implicated in sustaining fibrotic responses in chronic liver disease.130 In animal models and diseased human liver, lymphocytes are seen in close association with fibroblasts in inflamed portal tracts and fibrous septa, suggesting the involvement of
Summary
Advances in our understanding of liver fibrosis have highlighted the importance of interactions between liver fibroblasts and the innate and adaptive arms of the immune system in determining the outcome following tissue injury. Although many acute injuries to the liver result in self-limiting nonfibrotic inflammatory reactions, chronic hepatitis is associated with persistent inflammation and scarring because the development of a stromal microenvironment comprising modified neomatrix, activated
References (147)
- et al.
Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation
Trends Immunol
(2001) - et al.
Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair
Am J Pathol
(1999) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
J Biol Chem
(2000)- et al.
Targeting the stromal microenvironment in chronic inflammation
Curr Opin Pharmacol
(2006) - et al.
A stromal address code defined by fibroblasts
Trends Immunol
(2005) - et al.
Blood monocytes consist of two principal subsets with distinct migratory properties
Immunity
(2003) - et al.
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
J Hepatol
(2006) - et al.
Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research
J Hepatol
(2002) - et al.
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
J Hepatol
(2006) - et al.
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
Gastroenterology
(2006)
Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis
Hepatol Res
Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma
Autoimmun Rev
Effects of gadolinium chloride (GdCl(3)) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions
J Comp Pathol
Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats
Gastroenterology
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts
Cell Immunol
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction
Blood
Interleukin-10 secretion differentiates dendritic cells from human liver and skin
Am J Pathol
Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function
J Hepatol
Ito cells are liver-resident antigen-presenting cells for activating T cell responses
Immunity
Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype
Hepatology
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells
Gastroenterology
From fat to inflammation
Gastroenterology
LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors
Biochem Biophys Res Commun
Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury
Am J Pathol
Liver fibrosis: from the bench to clinical targets
Dig Liver Dis
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers
J Hepatol
Leukocyte extravasation: chemokine transport and presentation by the endothelium
Blood
Three-dimensional observations of the human hepatic artery (arterial system in the liver)
J Hepatol
Expression of E-selectin and E-selectin ligands in human liver inflammation
Hepatology
Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium
Gastroenterology
Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells
Hepatology
CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow
Am J Pathol
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans
J Hepatol.
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
J Clin Invest
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
J Clin Invest
Lymphocyte-hepatic stellate cell proximity suggests a direct interaction
Clin Exp Immunol
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
Physiol Rev
Hepatic stellate cell behavior during resolution of liver injury
Semin Liver Dis
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites
J Immunol
Monocyte and macrophage heterogeneity
Nat Rev Immunol
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
J Clin Invest
The role of circulating fibrocytes in fibrosis
Curr Rheumatol Rep
Discrimination of fibroblast subtypes by multivariate analysis of gene expression
Int J Cancer
Diversity, topographic differentiation, and positional memory in human fibroblasts
Proc Natl Acad Sci U S A
Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues
Int J Cancer
A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations
Hepatology
Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint
Arthritis Rheum
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
J Exp Med
Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury
Am J Physiol Gastrointest Liver Physiol
Cytokines and fibrogenesis
Semin Liver Dis
Cited by (93)
MANF brakes TLR4 signaling by competitively binding S100A8 with S100A9 to regulate macrophage phenotypes in hepatic fibrosis
2023, Acta Pharmaceutica Sinica BRole of phospholipase in liver and kidney fibrosis
2023, Phospholipases in Physiology and Pathology: Volumes 1-7Camphor elicits up-regulation of hepatic and pulmonary pro-inflammatory cytokines and chemokines via activation of NF-kB in rats
2019, PathophysiologyCitation Excerpt :The present study investigated the effect of various doses of camphor in an acute study, on hepatic and pulmonary levels of some pro-inflammatory cytokines and chemokines in rats. The inflammatory response that occurs during chronic hepatic injury is a dynamic process with intra-hepatic accumulation of different immune cells (helper T cells, dendritic cells and macrophages) [17]. The recruitment and migration of these cells depend on the pattern of cytokines and chemokines that are produced by hepatocytes, endothelial cells, and biliary epithelial cells [18,19].
Dr. Holt is supported by grants from the Medical Research Council, British Liver Trust, and Core.